期刊文献+

垂体泌乳素腺瘤药物治疗进展 被引量:4

Advances in drug therapy of prolactinomas
原文传递
导出
摘要 泌乳素(prolactin.PRL)腺瘤是最常见的颅内肿瘤之一,约占垂体腺瘤的60%。其临床表现包括闭经、泌乳、不孕、头痛、视力障碍及垂体功能低下等。治疗方法包括药物治疗、手术治疗及放射治疗。由于以多巴胺激动剂(dopamineagonist,DA)为主的药物治疗不仅可以使PRL水平下降、性腺功能恢复正常,而且可以使肿瘤体积缩小、避免手术,所以得到了较快的发展。本文就泌乳素腺瘤药物治疗进展做一简要综述。
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第9期955-957,共3页 Chinese Journal of Neuromedicine
关键词 垂体肿瘤 泌乳素腺瘤 药物疗法 Pituitary neoplasms Prolactinoma Drag therapy
  • 相关文献

参考文献19

  • 1Colao A, Di Samo A, Guerra E, et al. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women [J]. Nat Clin Pratt Endocrinol Metab, 2006, 2 (4): 200-210.
  • 2Gillam MP, Molitch ME, Lombardi G, et al. Advances in the treatment ofprolactinomas[J]. Endoer Rev, 2006, 27(5): 485-534.
  • 3Laloi-Michelin M, Ciraru-Vigneron N, Meas T. Cabergoline treatment of pregnant women with macroprolactinomas [J]. Int J Gynaecol Obstet, 2007, 99( 1 ): 61-62.
  • 4Jiang YN, Li YH, Ke MW, et al. Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromoeriptine induced apoptosis[J]. Cancer Cell Int, 2007, 7: 1.
  • 5Manuchehri AM, Sathyapalan T, Lowry M, et al. Effect ofdopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MR1) [J]. Pituitary, 2007, 10(3): 261-266.
  • 6Yu C, Wu Z, Gong J. Combined treatment of invasive giant prolactinomas[J]. Pituitary, 2005, 8(1): 61-65.
  • 7于春江,吴哲褒.侵袭性巨大泌乳素腺瘤的综合治疗(附30例报告)[J].中华神经外科杂志,2004,20(2):136-140. 被引量:16
  • 8Wu ZB, Yu CJ, Su ZP, et al. Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up[J]. J Neurosurg, 2006, 104(1): 54-61.
  • 9Shimon I, Benbassat C, Hadani M. Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men[J]. Eur J Endoerinol, 2007, 156(2): 225-231.
  • 10Cristina C, Diaz-Torga GS, Goya RG, et al. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes[J]. Mol Cancer, 2007, 6: 4.

二级参考文献36

  • 1初明,胡志强,魏兰兰,张树卓,胡恩喜,董齐.白黎芦醇对垂体腺瘤GH3细胞的抑制作用[J].中华神经外科杂志,2005,21(2):105-109. 被引量:8
  • 2Orlandi F, Saggiorato E, Pivano G, et al. Galactin - 3 is a presurgical marker of human thyroid carcinoma [J]. Cancer Res, 1908,58(14):3015 - 3020.
  • 3Yin H, Fujimoto N, Maruyama S, et al. Strain difference in regulation of pituitary tumor transforming gent (PTTG) in estrogen-induced pituitary tumorigenesis in rats[J]. J Cancer Res, 2001,92(10):1034 - 1040.
  • 4Xu RK, Wu XM, Di AK, et al. Pituitary Prolactin - secreting tumor formation: Recent developments[J]. Biol Signals Recept, 2000,9(1):19-20.
  • 5Azouzi M,Hsu DW,Black PM, et al. The importance of dopamine in the pathogenesis of experimental prolactinomas [J]. J Neurosurg,1990,72(2):273-281.
  • 6Flalachmi S, Marden E, Martin G, et al. Oestrogen receptor-associated proteins: Possible mediators of hormone induced transcription [J].Science, 1994,263 : 1455 - 1458.
  • 7Schmidt BMW, Gerdes D, Feuring M, et al. Rapid, nongenomic steroid actions - a new age [J]. Frontiers in Neuroendocrinology,2000,21 : 57 - 94.
  • 8Heaney AP, Horwitz GA, Wang Z, et al. Early involvement of estrogeninduced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis[J]. Nat Med, 1999,5:1317 - 1321.
  • 9Schlecthe JA. Prolactinoma[J]. Curr Ther Endocrinol Metab Curr Endocrinol Metab, 1997,6 : 45 - 47.
  • 10Yin P, Arita J. Differential regulation of prolactin release and lactotrope proliferation during pregnancy, lactation anti the estrous cycle[J]. Neuroendocrinology, 2000,72 (2) : 72 - 79.

共引文献19

同被引文献49

  • 1刘素彬,王树凯,周辉,宗庆华,李艳新.泌乳素垂体腺瘤的临床诊断及治疗[J].中国实用医刊,2010,37(5):41-42. 被引量:4
  • 2杨业洲.高催乳素血症生育过程的管理[J].实用妇产科杂志,2007,23(2):75-77. 被引量:4
  • 3Ciccarelli A, Daly AF, Beckers A.The epidemiology of prolactino- mas[J].Pituitary, 2005,8 : 3-6.
  • 4Buurman H,Saeger W. Subclinical adenomas in postmortem Pitu- itaries:classification and correlations to clinical data[J]. Eur J En- doerinol, 2006,154 (5) : 753-758.
  • 5Kelley KW,Weigent DA,Kooijman R.Protein hormones and im- munity [J]. Brain Behav Immun ,2007,21 (4) : 384-392.
  • 6Shi JS,Li D,Li N,et al. Inhibition of L-type calcium currents by salusin-beta in rat cardiac venticular myocytes[J]. Peptides,2010, 31(6) :1146-1149.
  • 7Clao A,Annunziato L,Lombardi G,Treatment of prolactinomas[J]. Ann Med,2003,30 (5) :452-459.
  • 8Manci T,Casanueva FF,Giustina A .Hyperprolactinemia and pro- lactinomas [J] .Endocrinol Metab North Am, 2008,37 ( 1 ) : 67-99.
  • 9Colao A.Di Samo A.Guerra E,et al.Drug insight :Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women[J].Nat CIin Pratt Endocrino! Metab, 2006,2 (4) : 200-210.
  • 10Chiodini L,Liuzzi A .PRL-secreting pituitary adenomas in preg- nancy[J]. J Endoccrinol Invest, 2003,26( 1 ):96-99.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部